A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
Clinical trial NCT04071366 · COMPLETED
Trial details
- NCT number
- NCT04071366
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-07
- Primary completion
- 2023-02-23
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.